Antibody response to COVID-19 vaccination in patients on chronic hemodialysis

PURPOSE: Since patients on hemodialysis (HD) are known to be vulnerable to coronavirus disease 2019 (COVID-19), many studies were conducted regarding the effectiveness of the COVID-19 vaccine in HD patients in Western countries. Here, we assessed antibody response of HD patients for 6 months post-va...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Heejung, Han, Sungdam, Kim, Ji Su, Park, Bumhee, Lee, Min-Jeong, Shin, Gyu-Tae, Kim, Heungsoo, Kim, Kyongmin, Park, A-Young, Shin, Ho-Joon, Park, Inwhee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435770/
https://www.ncbi.nlm.nih.gov/pubmed/37599806
http://dx.doi.org/10.7774/cevr.2023.12.3.249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435770/
https://www.ncbi.nlm.nih.gov/pubmed/37599806
http://dx.doi.org/10.7774/cevr.2023.12.3.249

Ejemplares similares